{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:08:23Z","timestamp":1793023703452,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Chongqing Health and Family Planning Commission","award":["2017MSXM023"],"award-info":[{"award-number":["2017MSXM023"]}]},{"name":"Chongqing Health and Family Planning Commission","award":["2017ZBXM046"],"award-info":[{"award-number":["2017ZBXM046"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","strokejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104682","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T16:50:14Z","timestamp":1586969414000},"page":"104682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"29","author":[{"given":"Shiyu","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youdong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0001","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1212\/WNL.30.12.1303","article-title":"The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture","volume":"30","author":"Lance","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/01.STR.0000105386.05173.5E","article-title":"Spasticity after stroke: its occurrence and association with motor impairments and activity limitations","volume":"35","author":"Sommerfeld","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0003","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1468-1331.2009.02915.x","article-title":"Location and severity of spasticity in the first 1-2weeks and at 3 and 18 months after stroke","volume":"17","author":"Welmer","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0004","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ana.410050620","article-title":"Impairment of voluntary movement by spasticity","volume":"5","author":"Mizrahi","year":"1979","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0005","first-page":"4","article-title":"Objective assessment of spasticity, strength, and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized double-blind study","volume":"73","author":"Katrak","year":"1992","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0006","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/PHM.0000000000000208","article-title":"Systematic literature review of abobotulinumtoxinA in clinical trials for adult upper limb spasticity","volume":"94","author":"Dashtipour","year":"2015","journal-title":"Am J Phys Med Rehab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0007","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1468-1331.2001.00277.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke","volume":"8","author":"Bakheit","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0008","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/01.STR.31.10.2402","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke","volume":"31","author":"Bakheit","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0009","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0010","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.apmr.2003.10.015","article-title":"Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke 1 \u2606","volume":"85","author":"Childers","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0011","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0269215511421355","article-title":"An early botulinum toxin A treatment in subacute stroke patients may prevent a disabling finger flexor stiffness six months later: a randomized controlled trial","volume":"68","author":"Hesse","year":"2012","journal-title":"Clini Rehabil"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0012","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1185\/03007995.2010.497103","article-title":"Botulinum toxin type A in post-stroke upper limb spasticity","volume":"26","author":"Kaji","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0013","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2340\/16501977-0366","article-title":"Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes","volume":"41","author":"Mccrory","year":"2009","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14260","article-title":"BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A","volume":"14","author":"Shaw","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0015","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/STROKEAHA.110.582197","article-title":"Botulinum toxin for the upper limb after stroke (BoTULS) trial effect on impairment, activity limitation, and pain","volume":"42","author":"Shaw","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0016","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.46.5.1306","article-title":"Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Simpson","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0017","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.apmr.2012.12.006","article-title":"Treatment with botulinum toxin improves upper-extremity function post stroke: a systematic review and meta-analysis","volume":"94","author":"Foley","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0018","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00702-007-0869-3","article-title":"Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity","volume":"115","author":"Rosales","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0019","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/S0004-282X2005000100006","article-title":"Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis","volume":"63","author":"Cardoso","year":"2005","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/mds.23426","article-title":"Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis","volume":"26","author":"Yablon","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.jstrokecerebrovasdis.2020.104682_bib0021","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8329306","article-title":"Efficacy and safety of botulinum toxin type A for limb spasticity after stroke: a meta-analysis of randomized controlled trials","author":"Sun","year":"2019","journal-title":"BioMed Res Int"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305720300537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305720300537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:44:52Z","timestamp":1760942692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305720300537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1052305720300537"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104682","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Stroke and Cerebrovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104682"}}